These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33042279)

  • 1. Intracellular calcium current disorder and disease phenotype in
    Chen P; Xiao Y; Wang Y; Zheng Z; Chen L; Yang X; Li J; Wu W; Zhang S
    Theranostics; 2020; 10(24):11215-11229. PubMed ID: 33042279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
    Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
    Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
    Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
    Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrical dysfunctions in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with an arrhythmogenic right ventricular cardiomyopathy.
    El-Battrawy I; Zhao Z; Lan H; Cyganek L; Tombers C; Li X; Buljubasic F; Lang S; Tiburcy M; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou XB; Akin I
    Europace; 2018 Jun; 20(FI1):f46-f56. PubMed ID: 29566126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.
    Kim C; Wong J; Wen J; Wang S; Wang C; Spiering S; Kan NG; Forcales S; Puri PL; Leone TC; Marine JE; Calkins H; Kelly DP; Judge DP; Chen HS
    Nature; 2013 Feb; 494(7435):105-10. PubMed ID: 23354045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering the Role of Wnt and Rho Signaling Pathway in iPSC-Derived ARVC Cardiomyocytes by In Silico Mathematical Modeling.
    Parrotta EI; Procopio A; Scalise S; Esposito C; Nicoletta G; Santamaria G; De Angelis MT; Dorn T; Moretti A; Laugwitz KL; Montefusco F; Cosentino C; Cuda G
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial expression profiles of candidate molecules in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia compared to those with dilated cardiomyopathy and healthy controls.
    Akdis D; Medeiros-Domingo A; Gaertner-Rommel A; Kast JI; Enseleit F; Bode P; Klingel K; Kandolf R; Renois F; Andreoletti L; Akdis CA; Milting H; Lüscher TF; Brunckhorst C; Saguner AM; Duru F
    Heart Rhythm; 2016 Mar; 13(3):731-41. PubMed ID: 26569459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maturation-Based Model of Arrhythmogenic Right Ventricular Dysplasia Using Patient-Specific Induced Pluripotent Stem Cells.
    Wen JY; Wei CY; Shah K; Wong J; Wang C; Chen HS
    Circ J; 2015; 79(7):1402-8. PubMed ID: 25971409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis.
    Te Riele AS; Agullo-Pascual E; James CA; Leo-Macias A; Cerrone M; Zhang M; Lin X; Lin B; Sobreira NL; Amat-Alarcon N; Marsman RF; Murray B; Tichnell C; van der Heijden JF; Dooijes D; van Veen TA; Tandri H; Fowler SJ; Hauer RN; Tomaselli G; van den Berg MP; Taylor MR; Brun F; Sinagra G; Wilde AA; Mestroni L; Bezzina CR; Calkins H; Peter van Tintelen J; Bu L; Delmar M; Judge DP
    Cardiovasc Res; 2017 Jan; 113(1):102-111. PubMed ID: 28069705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of obscurin immunoglobulin domains Ig58/59 leads to age-dependent cardiac remodeling and arrhythmia.
    Grogan A; Coleman A; Joca H; Granzier H; Russel MW; Ward CW; Kontrogianni-Konstantopoulos A
    Basic Res Cardiol; 2020 Sep; 115(6):60. PubMed ID: 32910221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired Intracellular Ca
    Pierantozzi E; Szentesi P; Paolini C; Dienes B; Fodor J; Oláh T; Colombini B; Rassier DE; Rubino EM; Lange S; Rossi D; Csernoch L; Bagni MA; Reggiani C; Sorrentino V
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restrictive loss of plakoglobin in cardiomyocytes leads to arrhythmogenic cardiomyopathy.
    Li D; Liu Y; Maruyama M; Zhu W; Chen H; Zhang W; Reuter S; Lin SF; Haneline LS; Field LJ; Chen PS; Shou W
    Hum Mol Genet; 2011 Dec; 20(23):4582-96. PubMed ID: 21880664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of differentially expressed microRNAs in arrhythmogenic right ventricular cardiomyopathy.
    Zhang H; Liu S; Dong T; Yang J; Xie Y; Wu Y; Kang K; Hu S; Gou D; Wei Y
    Sci Rep; 2016 Jun; 6():28101. PubMed ID: 27307080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrhythmogenic Cardiomyopathy: the Guilty Party in Adipogenesis.
    Stadiotti I; Catto V; Casella M; Tondo C; Pompilio G; Sommariva E
    J Cardiovasc Transl Res; 2017 Dec; 10(5-6):446-454. PubMed ID: 28983804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy.
    Forleo C; Carmosino M; Resta N; Rampazzo A; Valecce R; Sorrentino S; Iacoviello M; Pisani F; Procino G; Gerbino A; Scardapane A; Simone C; Calore M; Torretta S; Svelto M; Favale S
    PLoS One; 2015; 10(4):e0121723. PubMed ID: 25837155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal connexin43 in arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 mutations.
    Fidler LM; Wilson GJ; Liu F; Cui X; Scherer SW; Taylor GP; Hamilton RM
    J Cell Mol Med; 2009 Oct; 13(10):4219-28. PubMed ID: 18662195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin β1D Deficiency-Mediated RyR2 Dysfunction Contributes to Catecholamine-Sensitive Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Wang Y; Li C; Shi L; Chen X; Cui C; Huang J; Chen B; Hall DD; Pan Z; Lu M; Hong J; Song LS; Zhao S
    Circulation; 2020 May; 141(18):1477-1493. PubMed ID: 32122157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmogenic right ventricular cardiomyopathy mutations alter shear response without changes in cell-cell adhesion.
    Hariharan V; Asimaki A; Michaelson JE; Plovie E; MacRae CA; Saffitz JE; Huang H
    Cardiovasc Res; 2014 Nov; 104(2):280-9. PubMed ID: 25253076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel OBSCN variants associated with a risk to exercise-intolerance and rhabdomyolysis.
    Zemorshidi F; Töpf A; Claeys KG; McFarlane A; Patton A; Nafissi S; Straub V
    Neuromuscul Disord; 2024 Jan; 34():83-88. PubMed ID: 38159459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3β.
    Padrón-Barthe L; Villalba-Orero M; Gómez-Salinero JM; Domínguez F; Román M; Larrasa-Alonso J; Ortiz-Sánchez P; Martínez F; López-Olañeta M; Bonzón-Kulichenko E; Vázquez J; Martí-Gómez C; Santiago DJ; Prados B; Giovinazzo G; Gómez-Gaviro MV; Priori S; Garcia-Pavia P; Lara-Pezzi E
    Circulation; 2019 Oct; 140(14):1188-1204. PubMed ID: 31567019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.